With a $2 million grant from the National Institutes of Health, scientists from the University of Rochester Medical Center and Rochester Institute of Technology will enroll up to 300 people at risk ...
When you have transthyretin amyloid cardiomyopathy (ATTR-CM), proteins called amyloids build up in your heart, stiffening the muscle and interfering with its ability to pump blood throughout the body.